BOWEL & CANCER RESEARCH

05951118
Active London

Other research and experimental development on natural sciences and engineering

0 employees website.com
Other research and experimental development on natural sciences and engineering
B

BOWEL & CANCER RESEARCH

05951118

Other research and experimental development on natural sciences and engineering

Founded 29 Sept 2006 Active London, United Kingdom 0 employees website.com
Other research and experimental development on natural sciences and engineering

Previous Company Names

BOWEL AND CANCER RESEARCH 29 Sept 2006 — 16 Mar 2017
Accounts Submitted 26 Jun 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 25 Sept 2025 Next due 7 Oct 2026 3 months remaining
Net assets £609K £0 2022 year on year
Total assets £609K £0 2022 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

1st Floor Abernethy Building 2 Newark Street London E1 2AT

Full company profile for BOWEL & CANCER RESEARCH (05951118), an active company based in London, United Kingdom. Incorporated 29 Sept 2006. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2022
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2022)

Cash in Bank

N/A

Net Assets

£609.00k

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2022
31 Dec Year End
2021
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
25 Sept 2025OfficersTermination of Richard James Charles Pertwee as director on 14 May 2025
25 Sept 2025Confirmation StatementConfirmation statement made on 23 Sept 2025 with no updates
26 Jun 2025AccountsAnnual accounts made up to 31 Dec 2024
22 Oct 2024AccountsAnnual accounts made up to 31 Dec 2023
26 Sept 2024Confirmation StatementConfirmation statement made on 23 Sept 2024 with no updates
25 Sept 2025 Officers

Termination of Richard James Charles Pertwee as director on 14 May 2025

25 Sept 2025 Confirmation Statement

Confirmation statement made on 23 Sept 2025 with no updates

26 Jun 2025 Accounts

Annual accounts made up to 31 Dec 2024

22 Oct 2024 Accounts

Annual accounts made up to 31 Dec 2023

26 Sept 2024 Confirmation Statement

Confirmation statement made on 23 Sept 2024 with no updates

Recent Activity

Latest Activity

Termination of Richard James Charles Pertwee as director on 14 May 2025

9 months ago on 25 Sept 2025

Confirmation statement made on 23 Sept 2025 with no updates

9 months ago on 25 Sept 2025

Annual accounts made up to 31 Dec 2024

12 months ago on 26 Jun 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 22 Oct 2024

Confirmation statement made on 23 Sept 2024 with no updates

1 years ago on 26 Sept 2024